Brainstorm Cell Therapeutics Inc. ( $BCLI )

Recent earnings result

Events & Presentations

Supporting docs

1. Listen to webcast

Events & Annual meetings

Title	Date	Webcast
Brainstorm Cell Therapeutics Inc BCLI CEO Chaim Lebovits on Q3 2020 Results	10/21/2020	webcast

BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).

Videos about Brainstorm Cell Therapeutics Inc.

For list of BCLI events, you may visit their Investor Relations website.

Recent results

• $VZ - Verizon
  

  Verizon EPS beats by $0.03, misses on revenue

• $AN - AutoNation
  

  AutoNation EPS beats by $0.73, beats on revenue

• $HCSG - Healthcare Services Group, Inc.
  

  Healthcare Services EPS beats by $0.10, revenue in-line

• $WGO - Winnebago Industries Inc.
  

  Winnebago EPS beats by $0.52, beats on revenue

• $BKR - Baker Hughes
  

  Baker Hughes EPS in-line, beats on revenue

• $NDAQ - Nasdaq, Inc.
  

  Nasdaq EPS beats by $0.08, beats on revenue

• $TDY - Teledyne Technologies Incorporated
  

  Teledyne EPS beats by $0.10, misses on revenue

• $SCL - Stepan Company
  

  Stepan EPS beats by $0.16, beats on revenue

• $AVY - Avery Dennison Corp
  

  Avery Dennison EPS beats by $0.41, beats on revenue

• $FBC - Flagstar Bancorp, Inc.
  

  Flagstar EPS beats by $1.56